Ifrah Reut, Quevedo Lluisa, Hazrati Gal, Maman Shiran, Mangisto Huluager, Shmuel Eden, Gantz Liat
Department of Optometry and Vision Science, Hadassah Academic College, Jerusalem, Israel.
Faculty of Optics and Optometry, Universitat Politècnica de Catalunya, Terrassa, Spain.
Ophthalmic Physiol Opt. 2024 Jan;44(1):153-167. doi: 10.1111/opo.13247. Epub 2023 Nov 14.
This study investigated the equivocal association between contact lens (CL) wear and meibomian gland dysfunction (MGD) by comparing the morphological, functional and subjective outcomes of CL wearers versus control, non-CL wearers. CL wearers were examined as two cohorts based on the annual attendance of follow-up visits (FLU-attended these visits, whereas non-FLU did not).
Habitual logMAR visual acuity, invasive and non-invasive tear break-up time, Schirmer test, Efron grading scales, meibum quality score (MQS), meibum expressibility score (MES), meibomian gland (MG) loss, lid margin abnormalities and subjective dry eye (DE) symptoms were assessed.
Of the 128 participants, 31 were in the FLU cohort, 43 were in the non-FLU cohort and 54 were controls (mean ages: 22.2 ± 3.1, 23.0 ± 4.6 and 22.3 ± 3.5, respectively). Non-FLU CL wearers had more symptoms than controls (3.7 ± 2.4 vs. 2.3 ± 2.1, p < 0.01). Morphologically, FLU (16.9 ± 8.8%, p = 0.02) and non-FLU (18.6 ± 11.3%, p = 0.001) had more MG loss than controls (11.2 ± 6.8%). Functionally, FLU (0.6 ± 0.7, p = 0.01) and non-FLU (0.8 ± 0.9, p = 0.001) had worse MES than controls (0.2 ± 0.5). FLU and non-FLU were both associated with corneal staining (odds ratio [OR] = 3.42, 95% CI: 1.16-10.11, p = 0.03 and OR = 5.23, 95% CI: 1.89-14.48, p = 0.001, respectively) and MG loss (OR = 10.47, 95% CI: 1.14-96.29, p = 0.04 and OR = 16.63, 95% CI: 1.96-140.86, p = 0.01, respectively). Non-FLU CL wear was also associated with abnormal MQS (OR = 12.87, 95% CI: 1.12-148.41, p = 0.04), conjunctival staining (OR = 12.18, 95% CI: 3.66-40.51, p < 0.001) and lid margin telangiectasia (OR = 3.78, 95% CI: 1.55-9.21, p = 0.003). MGD was three times more prevalent in CL wearers (12%) than in controls (4%).
Both CL-wearing cohorts demonstrated significantly more MG abnormalities than controls though the difference was not clinically significant. Non-FLU CL wearers had more DE symptoms. Non-FLU CL wear is an independent predictor for more abnormalities than FLU CL wear, emphasising the importance of follow-ups.
本研究通过比较佩戴隐形眼镜(CL)者与对照非CL佩戴者的形态学、功能和主观结果,调查了CL佩戴与睑板腺功能障碍(MGD)之间存在争议的关联。根据随访就诊的年度出勤率将CL佩戴者分为两个队列(随访就诊者,而未随访就诊者则未参与)。
评估习惯性对数视力、侵入性和非侵入性泪膜破裂时间、泪液分泌试验、Efron分级量表、睑脂质量评分(MQS)、睑脂排出能力评分(MES)、睑板腺(MG)缺失、睑缘异常和主观干眼(DE)症状。
128名参与者中,31名属于随访就诊队列,43名属于未随访就诊队列,54名是对照组(平均年龄分别为:22.2±3.1岁、23.0±4.6岁和22.3±3.5岁)。未随访就诊的CL佩戴者比对照组有更多症状(3.7±2.4对2.3±2.1,p<0.01)。在形态学上,随访就诊组(16.9±8.8%,p=0.02)和未随访就诊组(18.6±11.3%,p=0.001)的MG缺失比对照组(11.2±6.8%)更多。在功能上,随访就诊组(0.6±0.7,p=0.01)和未随访就诊组(0.8±0.9,p=0.001)的MES比对照组(0.2±0.5)更差。随访就诊组和未随访就诊组均与角膜染色相关(优势比[OR]=3.42,95%可信区间:1.16 - 10.11,p=0.03和OR=5.23,95%可信区间:1.89 - 14.48,p=0.001)以及MG缺失相关(OR=10.47,95%可信区间:1.14 - 96.29,p=0.04和OR=16.63,95%可信区间:1.96 - 140.86,p=0.01)。未随访就诊的CL佩戴还与异常MQS(OR=12.87,95%可信区间:1.12 - 148.41,p=0.04)、结膜染色(OR=12.18,95%可信区间:3.66 - 40.51,p<0.001)和睑缘毛细血管扩张(OR=3.78,95%可信区间:1.55 - 9.21,p=0.003)相关。CL佩戴者中MGD的患病率(12%)是对照组(4%)的三倍。
两个CL佩戴队列均显示出比对照组明显更多的MG异常,尽管差异在临床上不显著。未随访就诊的CL佩戴者有更多的DE症状。未随访就诊的CL佩戴比随访就诊的CL佩戴是更多异常的独立预测因素,强调了随访的重要性。